Product Defect

Porsche Taycan Sudden Power Loss Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating Porsche over reports that their 2020-2021 Taycan model vehicles are prone to sudden and total loss of power while in use. The National Highway Traffic Safety Administration (NHTSA) recently announced a probe into the potential defect, citing numerous complaints received from owners of the luxury electric sedan. The […]

Consumer Protection

Plexcoin, Stripe Cryptocurrency Scheme Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating Stripe Inc. over allegations that it has put consumers at risk by failing to adequately assess risk and prevent, or subsequently mitigate fraud. Specifically, consumers have reported a pattern of unregulated and fraudulent dealings associated with cryptocurrency fraud sanctioned by Stripe’s lack of oversight, causing financial harm to […]

Product Defect

Tesla Touch Screen Failure Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating Tesla, Inc. over reports that the large touch screens prominently featured in their vehicles’ design and functionality may be prone to premature failure. Touch screen failure means the loss of rearview camera functionality, thus reducing visibility. Other features that require touch screen functionality include navigation, infotainment, and web […]

Product Defect

Metformin Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the widely used diabetes drug metformin, known by the common brand names Glucofage, Riomet, and Glumetza, for product contamination. Online pharmacy Valisure tested various metformin batches for impurities containing N-nitrosodimethylamine, or NDMA, a probable human carcinogen, and found sixteen contaminated batches. One batch contained sixteen times […]

Product Defect

Ranitidine Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating manufacturers of the prescription and over-the-counter heartburn medication ranitidine, known by the brand name Zantac. The U.S. Food and Drug Administration (FDA) recently requested manufacturers pull the drug from the market, citing an ongoing investigation that found many ranitidine samples contained hazardous levels of the contaminant NDMA, a […]